You are an investigator for a human-subjects research project at Covered Entity A. You have in your possession a data set containing PHI of 500 internally recruited study participants/patients of Covered Entity A.

Discuss and analyze:

1. How you would obtain consents, authorizations, IRB approval, and/or waivers for the use of PHI.
2. How you wouldas an alternative to using PHI for your studyde-identify the data set.
3. Any other HIPAA-related considerations you may take into account while conducting your study.